Drug comparisons
Acarbose vs Repaglinide
Compare Acarbose (Precose) vs Repaglinide for type 2 diabetes: mechanisms, efficacy, GI vs hypo risks, and which oral agent may fit post-meal control needs.
No comparison dimensions are available for this page.
Clinical context
Type 2 diabetes patients needing an oral agent focused on postprandial glucose spikes often compare an alpha-glucosidase inhibitor versus a meglitinide.
Bottom line
Acarbose is generally safer regarding hypoglycemia while Repaglinide typically provides more potent glycemic control, so selection hinges on individual risk factors.
All medication comparisons